Coverage at a glance
| Indication | Coverage |
|---|---|
| Weight loss only, standard plans | Not covered |
| Weight loss, on a plan that bought the rider | Covered with prior authorization |
| Type 2 diabetes and cardiovascular disease | Covered with prior authorization |
If your plan denies coverage, two cash programs to check.
- Strut Health$149 a month, with auto-refillcompounded semaglutide, not FDA-approvedCheck price →
- Shed$199 a monthcompounded semaglutide, not FDA-approvedCheck price →
Prior authorization: the plan reviews the prescription before it pays.
Independence Blue Cross stopped covering drugs prescribed only to lose weight on January 1, 2025. The change applies to fully insured group and individual commercial members. The Select Drug Program formulary, effective July 1, 2026, lists Wegovy and Zepbound as preferred brands and marks both R, which its key reads as Requires Rider. Both also need prior authorization and carry a quantity limit. GLP-1s stay covered with prior authorization for type 2 diabetes and cardiovascular disease. This answer covers Commercial fully insured plans, individual and group.
Source: Independence Blue Cross, Changes coming to weight loss drug coverage benefits, effective January 1, 2025. Checked September 7, 2026.
Where your plan lists it. The Select Drug Program formulary puts Wegovy and Zepbound on the preferred brand tier and marks both R for the rider. Ozempic, Mounjaro and Rybelsus sit on the same tier with prior authorization and a quantity limit, and no R. The formulary does not print copay amounts, and it says benefits vary by group. Source: Independence Blue Cross Select Drug Program Formulary, effective July 1, 2026.
Coverage by indication
Independence Blue Cross stopped covering drugs prescribed only to lose weight, GLP-1s among them, where there is no other FDA-approved indication. Its notice to providers, dated November 1, 2024, says the change is part of standard benefits for fully insured group and individual commercial members, and that a member who keeps taking the drug pays the full cost from January 1, 2025 or from the plan's renewal.
| Effective date | January 1, 2025 |
Source: Independence Blue Cross, Changes coming to weight loss drug coverage benefits, effective January 1, 2025. The plan's own page for providers, read as HTML.
The Select Drug Program formulary, effective July 1, 2026, lists Wegovy and Zepbound as preferred brands and marks both R. Its note reads: coverage of certain drugs on the formulary, for example weight loss drugs, requires a benefit rider. It also says prescription drug benefits vary by group. Call the number on your card to find out whether your plan bought the rider.
What the prior authorization needs:
- Your plan has to carry the weight-loss drug rider
- Prior authorization is required
- A quantity limit applies
Source: Independence Blue Cross Select Drug Program Formulary, effective July 1, 2026. The plan's own formulary, read as PDF.
Independence Blue Cross says it keeps paying for GLP-1s prescribed for FDA-approved medical conditions, and it names type 2 diabetes and cardiovascular disease, with prior authorization.
What the prior authorization needs:
- The file has to show an FDA-approved medical use: type 2 diabetes, or cardiovascular disease
- Prior authorization is required
- Ozempic, Mounjaro and Rybelsus are preferred brands with prior authorization and a quantity limit on the Select Drug Program formulary effective July 1, 2026, and none of the three carries the R rider code
Source: Independence Blue Cross, Changes coming to weight loss drug coverage benefits, effective January 1, 2025. The plan's own page for providers, read as HTML.
What to do next
If you qualify under one of the covered indications above, prior authorization is the path. Match the documentation in the requirements list then have your prescriber submit it. Plans that approve reassess at renewal, so know your long-term maintenance dose before you start.
- Browse the prior-authorization letter library for a template that matches your plan and indication.
- Read why plans say no and the four ways to appeal in the GLP-1 insurance guide.
- If the plan denies it, the appeal letter library has a template for each reason a plan gives. That covers the peer-to-peer call with a plan doctor, the Level 1 and Level 2 appeals inside the plan, and the outside review that follows them.
- If your plan does not cover the indication you need, compare cash prices in the cost guide or check whether a clinical trial near you fits. Neither one goes through your insurer. Clinical trials cost nothing and many pay you for your time.
What it costs without insurance
The programs below bill you directly. Prices checked every Monday.
Frequently asked questions
Does Independence Blue Cross cover Wegovy or Zepbound?
Not on a standard plan. Independence Blue Cross stopped covering drugs prescribed only for weight loss on January 1, 2025 for fully insured group and individual commercial members. Its Select Drug Program formulary, effective July 1, 2026, still lists both drugs as preferred brands and marks them R for the rider. Only plans that bought that rider cover them, with prior authorization and a quantity limit.
What does the R next to Wegovy on the Independence Blue Cross formulary mean?
It means the drug needs a benefit rider. The Select Drug Program formulary's key reads R as Requires Rider, and the guide says coverage of certain drugs on the formulary, weight loss drugs among them, requires one. If your plan did not buy that rider, the drug is not covered for weight loss even though it sits on the list.
Can I get a GLP-1 covered under Independence Blue Cross if I have type 2 diabetes?
Yes, with prior authorization. Independence Blue Cross says it kept covering GLP-1s prescribed for FDA-approved medical conditions when it dropped the weight-loss-only benefit on January 1, 2025, and it names type 2 diabetes and cardiovascular disease. On the July 2026 formulary Ozempic, Mounjaro and Rybelsus are preferred brands with prior authorization and a quantity limit, and none of the three carries the rider code.
Why did Independence Blue Cross stop covering GLP-1s for weight loss?
Its notice says the decision came down to what the drugs cost and what that does to premiums, and that the price in the United States is almost 10 times what it is in other parts of the world. It says higher premiums land on every member, not only the ones taking the drugs.
Coverage for other payers
See the full payer coverage index for every plan we have sourced.
How we built this page
Every page here comes from the payer's own policy, a federal law, or KFF's plan research. Each row links its source and gives the date we read it. Some plan files load at the address the payer gives but will not open. We check those against a second source and mark the row lower confidence. Job-based plans also choose whether to add the weight-drug benefit at all, so those rows say varies by plan rather than a flat yes.
This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.
